BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. It has been extensively studied for potential support of tendon and ligament repair, gut mucosal healing, muscle recovery, and angiogenesis at injury sites. It may act both locally when injected near an injury and systemically when taken orally for gut applications.

TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring protein involved in actin regulation. By promoting actin polymerization and associated repair pathways, TB-500 may support systemic tissue regeneration — including muscle, connective tissue, skin, and cardiac tissue — independently of the injection site.

How the BPC-157 + TB-500 Stack Works

BPC-157 and TB-500 are combined because their mechanisms are complementary rather than redundant. BPC-157 is particularly effective locally — for tendon-specific repair, gut healing, and site-specific angiogenesis. TB-500 works more systemically, addressing diffuse inflammation and broader tissue remodeling. Together they may provide more comprehensive recovery support than either compound alone.

Who Benefits Most From This Protocol

The BPC-157 and TB-500 stack may be most beneficial for individuals with tendon or ligament injuries that have been slow to heal, those with gut inflammatory conditions, post-surgical recovery patients, athletes experiencing overtraining syndrome, and adults over 40 with declining tissue repair capacity.

Protocol Considerations and Dosing Guidance

BPC-157 is commonly administered via subcutaneous or intramuscular injection near the site of injury, or orally for gut applications. TB-500 is administered subcutaneously. Both are typically cycled with a loading phase followed by a maintenance phase. Dosing should always be individualized by a physician based on the nature of the injury and overall health status.

Medically reviewed by Romy Fontoura, MD

BPC-157 and TB-500: The Recovery Stack Explained | Auryx

BPC-157 and TB-500 — how these two recovery peptides work, why they are often combined, who benefits most, and what the research shows. Written by Romy Fontoura, MD.

About this Auryx page

Auryx is an MD-led peptide therapy clinic that serves eligible patients nationwide via telemedicine. Founded and led by Romy Fontoura, MD, the practice designs physician-supervised protocols and fulfills approved compounds through regulated United States compounding pharmacies. Public pages are research and education. They do not replace personalized advice from a licensed clinician and they do not give dosing instructions.

For the catalog see shop. For compound encyclopedic notes see Learn. For physician-authored essays see the Journal. For the clinical process see our method. For leadership and review standards see about.

How to continue

Questions and scheduling go through contact or info@auryxlife.com. Citations sit on sources. Legal pages are privacy and terms. The English homepage is Auryx; Spanish and Portuguese overviews are /es and /pt.